reference/32572471

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32572471

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Controlled Clinical Trial\|Journal Article
endingPage	229
issn	0920-1211
issueIdentifier	3
pageRange	222-229
publicationName	Epilepsy Research
startingPage	222
bibliographicCitation	Binnie CD, Debets RM, Engelsman M, Meijer JW, Meinardi H, Overweg J, Peck AW, Van Wieringen A, Yuen WC. Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy. Epilepsy Res. 1989 Nov;4(3):222–9. doi: 10.1016/0920-1211(89)90007-7. PMID: 2612495.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b75fdd959f768e63d1d71d5322ba659 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c73cd86f5c62afbcda57be9fe1d8359 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_762408639e7306cbc41f0f2ac7932258 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c8bfc4bd7f2b51af6376866d40dd6e6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7bb97aed3eda299054ff2c49b1756a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7681ac2fb11176387eb56542c7d4a640 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c0c2e737476655611610a2d2bea30f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb9e10e54820cdd7fb1ed1b81533a3ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4f3f942f7e1300efb87671277039ce6
date	198911
identifier	https://doi.org/10.1016/0920-1211%2889%2990007-7 https://pubmed.ncbi.nlm.nih.gov/2612495
isPartOf	https://portal.issn.org/resource/ISSN/0920-1211 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy
discusses	http://id.nlm.nih.gov/mesh/M0001382 http://id.nlm.nih.gov/mesh/M0137818 http://id.nlm.nih.gov/mesh/M0021908 http://id.nlm.nih.gov/mesh/M0006823
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014227Q000627 http://id.nlm.nih.gov/mesh/D004833Q000188 http://id.nlm.nih.gov/mesh/D000927Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D014227Q000493 http://id.nlm.nih.gov/mesh/D000077213 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D014227Q000009 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D004338 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004833Q000503 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D004311
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6522 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3878 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617

Total number of triples: 53.